Table 1.
UniProt Accession |
Description and Gene name | Abundance Ratio: (auranofin treatment)/(negative control) | Abundance Ratio: (xanthine/xanthine oxidase treatment)/(negative control) | Abundance Ratio: (auranofin treatment)/(PBS treatment) | Abundance Ratio: (xanthine/xanthine oxidase treatment)/(PBS treatment) | Numbers of Cysteine residues | Sulphenylation sites |
---|---|---|---|---|---|---|---|
P07437a | Tubulin beta chain TUBB |
100 | 100 | 100 | 100 | 8 | |
P50395a | Rab GDP dissociation inhibitor GDI2 |
100 | 100 | 100 | 100 | 8 | C277, C302 [62] |
Q8WUM0a | Nuclear pore complex protein Nup133 NUP133 |
100 | 100 | 100 | 100 | 18 | |
P26196 | Probable ATP-dependent RNA helicase DDX6 DDX6 |
100 | 100 | 7 | C102 [62] | ||
P52756a | RNA-binding protein 5 RBM5 | 100 | 100 | 100 | 100 | 9 | |
Q01968a | Inositol polyphosphate 5-phosphatase OCRL-1 OCRL |
100 | 100 | 100 | 100 | 21 | |
Q9NTJ3 | Structural maintenance of chromosomes protein 4 SMC4 | 100 | 100 | 0.01 | 12 | C916 [62] | |
Q92905a | COP9 signalosome complex subunit 5 JAB1/CSN5/COPS5 |
100 | 100 | 9.446 | 13.886 | 4 | C218 [62] |
P68133 | Actin, alpha skeletal muscle ACTA1 | 19.794 | 100 | 1 | 100 | 6 | |
Q15393 | Splicing factor 3B subunit 3 SF3B3 | 15.795 | 100 | 8.318 | 100 | 19 | C269, C1054, C1156 [62] |
P61011 | Signal recognition particle 54 kDa protein SRP54 |
0.755 | 100 | 1 | 100 | 5 | |
Q9Y224 | RNA transcription, translation and transport factor protein C14orf166 |
100 | 0.01 | 100 | 2 | ||
O75694 | Nuclear pore complex protein Nup155 NUP155 |
1 | 100 | 0.869 | 100 | 28 |
Six potential Prdx2 interactor candidates marked with an asterisk are upregulated in both H2O2 elevating conditions.